Trial record 1 of 1 for:
NCT04631601
Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04631601 |
|
Recruitment Status :
Terminated
(Amgen made a business decision to discontinue all AMG 160 clinical trials. This decision is not related to safety.)
First Posted : November 17, 2020
Last Update Posted : November 7, 2023
|
Sponsor:
Amgen
Information provided by (Responsible Party):
Amgen
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | October 23, 2023 |
| Actual Study Completion Date : | October 23, 2023 |